Makoto Kunisada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Makoto Kunisada has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Chikako Nishigori
Division of Dermatology, Department of Internal Medicine, Graduate School of Medicine Kobe University Kobe Japan
15 shared publications Chikako Nishigori
Division of Research on Intractable Dermatological Disease, Department of iPS cell Applications Kobe University Graduate School of Medicine Kobe Japan
4 shared publications- Ai Yoshioka
Division of Dermatology, Department of Internal Related, Graduate School of Medicine Kobe University Kobe Japan
3 shared publications Aiko Nishiaki‐Sawada
Ushio Inc. Chiyoda‐ku, Tokyo Japan
3 shared publicationsChihiro Takemori
Division of Dermatology, Department of Internal Related, Graduate School of Medicine, Kobe University, Kobe, Japan
3 shared publicationsFlandiana Yogianti
3 shared publications
Latest Publications
- 20 May 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (7) , e591-e593
Phototesting‐Demonstrated Broad‐Spectrum Ultraviolet Photosensitivity Induced by Taletrectinib
- 20 May 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (7) , e591-e593
Phototesting‐Demonstrated Broad‐Spectrum Ultraviolet Photosensitivity Induced by Taletrectinib
- 22 March 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (6)
Clinical Practice Guidelines for the Management of Porphyrias in Japan: Secondary Publication (English Translation)
Porphyrias are rare metabolic disorders caused by decreased or increased activity of one of the nine enzymes involved in the heme biosynthetic pathway, resulting in the accumulation of porphyrins or their precursors. Although nine subtypes are currently recognized, substantial overlap in clinical manifestations often makes diagnosis challenging. This article presents the English version of the first national clinical practice guidelines for porphyrias in Japan, originally published in 2025 by the Japanese Dermatological Association. The guidelines were developed by the Clinical Practice Guideline Committee, established as part of the Research Project on Intractable Diseases of the Ministry of Health, Labour and Welfare of Japan. Diagnostic and severity assessment criteria were based on those proposed by the Ministry research group. Clinical questions (CQs) were formulated, and recommendations were developed according to the principles of evidence‐based medicine, incorporating both domestic and international evidence. The guidelines provide diagnostic criteria, severity classification, and evidence‐based recommendations for the management of porphyrias. Although causative genes have been identified, the pathophysiology remains incompletely understood, and no curative therapy is currently available, and liver transplantation may be required in severe cases with liver failure. These guidelines aim to provide practical guidance for clinicians managing porphyrias in Japan. Future revisions will be necessary in response to advances in diagnostic technologies and therapeutic strategies.
- 22 March 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (6)
Clinical Practice Guidelines for the Management of Porphyrias in Japan: Secondary Publication (English Translation)
Porphyrias are rare metabolic disorders caused by decreased or increased activity of one of the nine enzymes involved in the heme biosynthetic pathway, resulting in the accumulation of porphyrins or their precursors. Although nine subtypes are currently recognized, substantial overlap in clinical manifestations often makes diagnosis challenging. This article presents the English version of the first national clinical practice guidelines for porphyrias in Japan, originally published in 2025 by the Japanese Dermatological Association. The guidelines were developed by the Clinical Practice Guideline Committee, established as part of the Research Project on Intractable Diseases of the Ministry of Health, Labour and Welfare of Japan. Diagnostic and severity assessment criteria were based on those proposed by the Ministry research group. Clinical questions (CQs) were formulated, and recommendations were developed according to the principles of evidence‐based medicine, incorporating both domestic and international evidence. The guidelines provide diagnostic criteria, severity classification, and evidence‐based recommendations for the management of porphyrias. Although causative genes have been identified, the pathophysiology remains incompletely understood, and no curative therapy is currently available, and liver transplantation may be required in severe cases with liver failure. These guidelines aim to provide practical guidance for clinicians managing porphyrias in Japan. Future revisions will be necessary in response to advances in diagnostic technologies and therapeutic strategies.
- 31 January 2024
- Published by Wiley in The Journal of Dermatology
- Vol. 51 (6) , e211-e213
A case of nodular cutaneous amyloidosis presenting as refractory leg skin ulcers
- 31 January 2024
- Published by Wiley in The Journal of Dermatology
- Vol. 51 (6) , e211-e213
A case of nodular cutaneous amyloidosis presenting as refractory leg skin ulcers
- Open Access
- 8 December 2022
- Published by Wiley in Photochemistry and Photobiology
- Vol. 99 (2) , 335-343
Biological Impact of Shorter Wavelength Ultraviolet Radiation‐C†
Life on earth has constantly coped with the impact of solar radiation, especially solar ultraviolet radiation (solar UV). Various biological mechanisms protect us from solar UV. New devices emitting shorter wavelengths UV‐C, i.e. <254 nm emitted by conventional UV germicidal lamps, have emerged. These shorter wavelength UV‐C emitting devices are useful for various purposes, including microorganism inactivation. However, as solar UV‐C does not reach the earth surface, biological impacts of UV‐C has been studied using 254 nm germicidal lamps, and those using shorter wavelength UV‐C is rarely known. To balance the utility and risk of UV‐C, the biological effect of these new UV‐C emitting devices must be investigated. In addition, our knowledge of biological impacts of the wavelength‐dependent entire UV (100–400 nm) must be enhanced. In this review, we briefly summarize the biological impacts of shorter wavelength UV‐C. Mechanisms of UV‐C‐induced cellular damage and factors affecting the microorganism inactivation efficiency of UV‐C have been discussed. In addition, we theoretically estimate the probable photocarcinogenic action spectrum of shorter wavelength UV‐C. We propose that increasing the knowledge on UV‐C will facilitate the adoption of shorter wavelength UV‐C emitting new devices in an optimal and appropriate manner.
- 8 December 2022
- Published by Wiley in Photochemistry and Photobiology
- Vol. 99 (2) , 335-343
Open AccessBiological Impact of Shorter Wavelength Ultraviolet Radiation‐C†
Life on earth has constantly coped with the impact of solar radiation, especially solar ultraviolet radiation (solar UV). Various biological mechanisms protect us from solar UV. New devices emitting shorter wavelengths UV‐C, i.e. <254 nm emitted by conventional UV germicidal lamps, have emerged. These shorter wavelength UV‐C emitting devices are useful for various purposes, including microorganism inactivation. However, as solar UV‐C does not reach the earth surface, biological impacts of UV‐C has been studied using 254 nm germicidal lamps, and those using shorter wavelength UV‐C is rarely known. To balance the utility and risk of UV‐C, the biological effect of these new UV‐C emitting devices must be investigated. In addition, our knowledge of biological impacts of the wavelength‐dependent entire UV (100–400 nm) must be enhanced. In this review, we briefly summarize the biological impacts of shorter wavelength UV‐C. Mechanisms of UV‐C‐induced cellular damage and factors affecting the microorganism inactivation efficiency of UV‐C have been discussed. In addition, we theoretically estimate the probable photocarcinogenic action spectrum of shorter wavelength UV‐C. We propose that increasing the knowledge on UV‐C will facilitate the adoption of shorter wavelength UV‐C emitting new devices in an optimal and appropriate manner.
- 1 October 2022
- Published by Wiley in Experimental Dermatology
- Vol. 31 (10) , 1607-1617
The landscape of genetic alterations of UVB-induced skin tumors in DNA repair-deficient mice
Non-melanoma skin cancer (NMSC) is mainly caused by ultraviolet (UV)-induced somatic mutations and is characterized by UV signature modifications. Xeroderma pigmentosum group A (Xpa) knockout mice exhibit extreme UV-induced photo-skin carcinogenesis, along with a photosensitive phenotype. We performed whole-exome sequencing (WES) of squamous cell carcinoma (SCC) samples after repetitive ultraviolet B (UVB) exposure to investigate the differences in the landscape of somatic mutations between Xpa knockout and wild-type mice. Although the tumors that developed in mice harboured UV signature mutations in a similar set of cancer-related genes, the pattern of transcriptional strand asymmetry was largely different; UV signature mutations in Xpa knockout and wild-type mice preferentially occurred in transcribed and non-transcribed strands, respectively, reflecting a deficiency in transcription-coupled nucleotide excision repair in Xpa knockout mice. Serial time point analyses of WES for a tumor induced by only a single UVB exposure showed pathogenic mutations in Kras, Fat1, and Kmt2c, which may be driver genes for the initiation and promotion of SCC in Xpa knockout mice. Furthermore, the inhibitory effects on tumor production in Xpa knockout mice by the anti-inflammatory CXCL1 monoclonal antibody affected the pattern of somatic mutations, wherein the transcriptional strand asymmetry was attenuated and the activated signal transduction was shifted from the RAS/RAF/MAPK to the PIK3CA pathway.
- 1 October 2022
- Published by Wiley in Experimental Dermatology
- Vol. 31 (10) , 1607-1617
The landscape of genetic alterations of UVB-induced skin tumors in DNA repair-deficient mice
Non-melanoma skin cancer (NMSC) is mainly caused by ultraviolet (UV)-induced somatic mutations and is characterized by UV signature modifications. Xeroderma pigmentosum group A (Xpa) knockout mice exhibit extreme UV-induced photo-skin carcinogenesis, along with a photosensitive phenotype. We performed whole-exome sequencing (WES) of squamous cell carcinoma (SCC) samples after repetitive ultraviolet B (UVB) exposure to investigate the differences in the landscape of somatic mutations between Xpa knockout and wild-type mice. Although the tumors that developed in mice harboured UV signature mutations in a similar set of cancer-related genes, the pattern of transcriptional strand asymmetry was largely different; UV signature mutations in Xpa knockout and wild-type mice preferentially occurred in transcribed and non-transcribed strands, respectively, reflecting a deficiency in transcription-coupled nucleotide excision repair in Xpa knockout mice. Serial time point analyses of WES for a tumor induced by only a single UVB exposure showed pathogenic mutations in Kras, Fat1, and Kmt2c, which may be driver genes for the initiation and promotion of SCC in Xpa knockout mice. Furthermore, the inhibitory effects on tumor production in Xpa knockout mice by the anti-inflammatory CXCL1 monoclonal antibody affected the pattern of somatic mutations, wherein the transcriptional strand asymmetry was attenuated and the activated signal transduction was shifted from the RAS/RAF/MAPK to the PIK3CA pathway.
- 19 May 2022
- Published by Wiley in The Journal of Dermatology
- Vol. 49 (10) , E391-E392
Autoimmune progesterone dermatitis treated with dienogest: A case report
20 June 2025: This article has been temporarily removed due to privacy concerns.
- 19 May 2022
- Published by Wiley in The Journal of Dermatology
- Vol. 49 (10) , E391-E392
Autoimmune progesterone dermatitis treated with dienogest: A case report
20 June 2025: This article has been temporarily removed due to privacy concerns.
- 3 September 2021
- Published by Wiley in The Journal of Dermatology
- Vol. 48 (12) , E577-E578
Incontinentia pigmenti in a female infant with somatic mosaicism due to the IKBKG variant
- 3 September 2021
- Published by Wiley in The Journal of Dermatology
- Vol. 48 (12) , E577-E578
Incontinentia pigmenti in a female infant with somatic mosaicism due to the IKBKG variant
- Open Access
- 21 January 2021
- Published by Wiley in Photochemistry and Photobiology
- Vol. 97 (4) , 770-777
Evaluation of Acute Reactions on Mouse Skin Irradiated with 222 and 235 nm UV‐C
Biological response and DNA damage following irradiation with shorter wavelengths in the UV‐C range were evaluated to investigate the safety at three wavelengths because of the recent emergence of germicidal equipment emitting short‐wavelength UV‐C for various purposes, including medical uses. To estimate an acceptable safety dose for human skin in the UV‐C range, especially short UV‐C, we studied the biological effects of 207, 222 and 235 nm UV‐C using albino hairless mice and evaluated the inflammatory reactions in the skin. To explore an appropriate indicator to evaluate the biological response, we employed determination of the minimal perceptible response dose (MPRD), by which any subtle cutaneous response; erythema, edema and scale could be observed by visual inspection. Erythema was rarely observed, but edema and scale formation were evident for short UV‐C wavelengths. The MPRD at 207, 222 and 235 nm was determined to be > 15, 15 and 2.0 kJ m−2, respectively. These values could be thresholds and indicators for possible safety assessments. Our data suggest that the current human exposure limits for short UV‐C wavelengths below 254 nm are overly restrictive and should be reconsidered for future disinfection lamps with short UV‐C wavelengths.
- 21 January 2021
- Published by Wiley in Photochemistry and Photobiology
- Vol. 97 (4) , 770-777
Open AccessEvaluation of Acute Reactions on Mouse Skin Irradiated with 222 and 235 nm UV‐C
Biological response and DNA damage following irradiation with shorter wavelengths in the UV‐C range were evaluated to investigate the safety at three wavelengths because of the recent emergence of germicidal equipment emitting short‐wavelength UV‐C for various purposes, including medical uses. To estimate an acceptable safety dose for human skin in the UV‐C range, especially short UV‐C, we studied the biological effects of 207, 222 and 235 nm UV‐C using albino hairless mice and evaluated the inflammatory reactions in the skin. To explore an appropriate indicator to evaluate the biological response, we employed determination of the minimal perceptible response dose (MPRD), by which any subtle cutaneous response; erythema, edema and scale could be observed by visual inspection. Erythema was rarely observed, but edema and scale formation were evident for short UV‐C wavelengths. The MPRD at 207, 222 and 235 nm was determined to be > 15, 15 and 2.0 kJ m−2, respectively. These values could be thresholds and indicators for possible safety assessments. Our data suggest that the current human exposure limits for short UV‐C wavelengths below 254 nm are overly restrictive and should be reconsidered for future disinfection lamps with short UV‐C wavelengths.
- Top Cited PapersOpen Access
- 29 March 2020
- Published by Wiley in Photochemistry and Photobiology
- Vol. 96 (4) , 853-862
Long‐term Effects of 222‐nm ultraviolet radiation C Sterilizing Lamps on Mice Susceptible to Ultraviolet Radiation
Germicidal lamps that emit primarily 254 nm ultraviolet radiation (UV) are routinely utilized for surface sterilization but cannot be used for human skin because they cause genotoxicity. As an alternative, 222‐nm UVC has been reported to exert sterilizing ability comparable to that of 254‐nm UVC without producing cyclobutane pyrimidine dimers (CPDs), the major DNA lesions caused by UV. However, there has been no clear evidence for safety in chronic exposure to skin, particularly with respect to carcinogenesis. We therefore investigated the long‐term effects of 222‐nm UVC on skin using a highly photocarcinogenic phenotype mice that lack xeroderma pigmentosum complementation group A (Xpa‐) gene, which is involved in repairing of CPDs. CPDs formation was recognized only uppermost layer of epidermis even with high dose of 222‐nm UVC exposure. No tumors were observed in Xpa‐knockout mice and wild‐type mice by repetitive irradiation with 222‐nm UVC, using a protocol which had shown to produce tumor in Xpa‐knockout mice irradiated with broad‐band UVB. Furthermore, erythema and ear swelling were not observed in both genotype mice following 222‐nm UVC exposure. Our data suggest that 222‐nm UVC lamps can be safely used for sterilizing human skin as far as the perspective of skin cancer development.
- 29 March 2020
- Published by Wiley in Photochemistry and Photobiology
- Vol. 96 (4) , 853-862
Top Cited PapersOpen AccessLong‐term Effects of 222‐nm ultraviolet radiation C Sterilizing Lamps on Mice Susceptible to Ultraviolet Radiation
Germicidal lamps that emit primarily 254 nm ultraviolet radiation (UV) are routinely utilized for surface sterilization but cannot be used for human skin because they cause genotoxicity. As an alternative, 222‐nm UVC has been reported to exert sterilizing ability comparable to that of 254‐nm UVC without producing cyclobutane pyrimidine dimers (CPDs), the major DNA lesions caused by UV. However, there has been no clear evidence for safety in chronic exposure to skin, particularly with respect to carcinogenesis. We therefore investigated the long‐term effects of 222‐nm UVC on skin using a highly photocarcinogenic phenotype mice that lack xeroderma pigmentosum complementation group A (Xpa‐) gene, which is involved in repairing of CPDs. CPDs formation was recognized only uppermost layer of epidermis even with high dose of 222‐nm UVC exposure. No tumors were observed in Xpa‐knockout mice and wild‐type mice by repetitive irradiation with 222‐nm UVC, using a protocol which had shown to produce tumor in Xpa‐knockout mice irradiated with broad‐band UVB. Furthermore, erythema and ear swelling were not observed in both genotype mice following 222‐nm UVC exposure. Our data suggest that 222‐nm UVC lamps can be safely used for sterilizing human skin as far as the perspective of skin cancer development.
- 29 July 2019
- Published by Wiley in The Journal of Dermatology
- Vol. 46 (11) , e398-e400
Case of two lesions of dermatofibrosarcoma protuberans revealing identical COL1A1–PDGFB fusion gene: Skin metastasis or multicentric lesions?
- 29 July 2019
- Published by Wiley in The Journal of Dermatology
- Vol. 46 (11) , e398-e400
Case of two lesions of dermatofibrosarcoma protuberans revealing identical COL1A1–PDGFB fusion gene: Skin metastasis or multicentric lesions?